Sign in

NCT04735406Completed

The MS-LINK™ Outcomes Study

The MS-LINK™ Outcomes Study: A Comprehensive Prospective Longitudinal Assessment of Patient and Clinical Reported Outcomes in Multiple Sclerosis Patients Across North America

Source: ClinicalTrials.gov · Last updated 22 Aug 2024

Brief summary (registry, in English)

The Multiple Sclerosis (MS) Leadership and Innovation Network (MS-LINK™) is comprised of networks working cooperatively to advance Multiple Sclerosis (MS) science and improve MS participant outcomes. In this study participants will be followed from the time of consent through the lifetime of the study (currently 3 years), unless the participant chooses to withdraw from the study. Collection of participant's medical history, including MS and treatment history, will be automated through extraction from the participant's electronic medical record (EMR) and other health information systems (for example, radiology). Participants will complete patient-reported outcomes (PROs) and other health-related information digitally. Participating participants will have access to their own data in an ongoing manner via a web-based Participant Portal.

Status (registry)
Completed
Study type
Observational
Enrollment
2182 (actual)
First submitted
28 Jan 2021
Start date
24 Mar 2021
Primary completion date
31 Jan 2024
Lead sponsor
EMD Serono Research & Development Institute, Inc.
NCT number
NCT04735406

What you commit to

  • Study type: Observational
  • Participants enrolled: 2182
  • From 24 Mar 2021 to the primary completion date, 31 Jan 2024
  • 9 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participants participating in interventional clinical drug trials at baseline

Other

  • Unable to complete questionnaires in English
  • Unable to consistently access the Internet

Who the study is looking for

  • Participants willing and able to provide written informed consent
  • Participants willing to be contacted while participating in the study for recruitment into sub-studies that may be relevant to them
  • Participants willing and able to complete PROs on a monthly basis and document events of interest as they occur
  • Participants willing to participate in additional follow up at the site for at least three years

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (9)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Atlanta Neuroscience Institute
Coordinator of this site? Confirm its status
AtlantaUnited StatesUnknown status
The University of Texas of Austin
Coordinator of this site? Confirm its status
AustinUnited StatesUnknown status
Alabama Neurology Associates
Coordinator of this site? Confirm its status
BirminghamUnited StatesUnknown status
Beth Israel Deaconess Medical Center
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status
The Oklahoma Medical Research Foundation
Coordinator of this site? Confirm its status
Oklahoma CityUnited StatesUnknown status
University of Nebraska Medical Center
Coordinator of this site? Confirm its status
OmahaUnited StatesUnknown status
Memorial Healthcare
Coordinator of this site? Confirm its status
OwossoUnited StatesUnknown status
University of Texas Health
Coordinator of this site? Confirm its status
San AntonioUnited StatesUnknown status
Georgetown University
Coordinator of this site? Confirm its status
Washington D.C.United StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.